These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2097660)

  • 1. Effect of L-649, 923, an LTD4 antagonist, on phospholipase A2-induced hypotension.
    Cicala C; Sorrentino R; Sorrentino L; Cirino G
    Pharmacol Res; 1990; 22 Suppl 3():83. PubMed ID: 2097660
    [No Abstract]   [Full Text] [Related]  

  • 2. Phospholipase A2-induced hypotension in the rat and its pharmacological modulation.
    Cicala C; Cirino G
    Gen Pharmacol; 1993 Sep; 24(5):1197-202. PubMed ID: 8270179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of phospholipase A2-induced oedema in rat paw.
    Cirino G; Peers SH; Wallace JL; Flower RJ
    Eur J Pharmacol; 1989 Aug; 166(3):505-10. PubMed ID: 2806373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
    Sirén AL; Eimerl J; Feuerstein G
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma.
    Beck A; Sallmann A; Wenk P; Märki F; Bray MA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():771-4. PubMed ID: 2960189
    [No Abstract]   [Full Text] [Related]  

  • 6. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock.
    Vadas P; Hay JB
    Can J Physiol Pharmacol; 1983 Jun; 61(6):561-6. PubMed ID: 6883208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile.
    Bray MA; Beck A; Wenk P; Märki F; Subramanian N; Niederhauser U; Kuhn M; Sallmann A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():526-31. PubMed ID: 2959108
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
    Perico N; Pasini M; Gaspari F; Abbate M; Remuzzi G
    Transplantation; 1991 Nov; 52(5):873-8. PubMed ID: 1835198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of leukotrienes, thromboxane A2 and phospholipase A2 on human, porcine and guinea pig lung parenchyma.
    Zijlstra FJ; Vincent JE; Bonta IL
    Agents Actions; 1984 Jan; 14(1):88-92. PubMed ID: 6702513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock.
    Vadas P
    J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2-induced pulmonary and hemodynamic responses in the guinea pig. Effects of enzyme inhibitors and mediators antagonists.
    Tocker JE; Durham SK; Welton AF; Selig WM
    Am Rev Respir Dis; 1990 Nov; 142(5):1193-9. PubMed ID: 2240843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of an orally active leukotriene antagonist L-649,923 in normal man.
    Barnes NC; Piper PJ; Costello JF
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1000-2. PubMed ID: 2960141
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat.
    Li EJ; Cook JA; Ashton S; Wise WC; Halushka PV
    Eur J Pharmacol; 1991 Jun; 199(2):221-5. PubMed ID: 1954979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man.
    Barnes N; Piper PJ; Costello J
    J Allergy Clin Immunol; 1987 May; 79(5):816-21. PubMed ID: 3553279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological studies of stonefish (Synanceja trachynis) venom.
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1994 Oct; 32(10):1197-210. PubMed ID: 7846690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced phospholipase A2 activity in rat plasma, liver, and intestinal mucosa following endotoxin treatment: a possible explanation for the protective effect of indomethacin in endotoxic shock.
    Shakir KM; O'Brian JT; Gartner SL
    Metabolism; 1985 Feb; 34(2):176-82. PubMed ID: 3881649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
    Schädlich HR; Büchler M; Beger HG
    Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phospholipase A2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed.
    Kaye AD; Nossaman BD; Smith DE; Ibrahim IN; Imig JD; Kadowitz PJ
    Am J Physiol; 1997 Apr; 272(4 Pt 1):L573-9. PubMed ID: 9142927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
    Smith EF; Slivjak MJ; Egan JW; Eckardt RD; Newton JF
    Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.